1
|
Croce CM and Calin GA: miRNAs, cancer, and
stem cell division. Cell. 122:6–7. 2005. View Article : Google Scholar : PubMed/NCBI
|
2
|
Iorio MV and Croce CM: MicroRNAs in
cancer: small molecules with a huge impact. J Clin Oncol.
27:5848–5856. 2009. View Article : Google Scholar : PubMed/NCBI
|
3
|
Lee RC, Feinbaum RL and Ambros V: The
C. elegans heterochronic gene lin-4 encodes small RNAs with
antisense complementarity to lin-14. Cell. 75:843–854. 1993.
|
4
|
Grimson A, Farh KK, Johnston WK,
Garrett-Engele P, Lim LP and Bartel DP: MicroRNA targeting
specificity in mammals: determinants beyond seed pairing. Mol Cell.
27:91–105. 2007. View Article : Google Scholar : PubMed/NCBI
|
5
|
Mertens-Talcott SU, Chintharlapalli S, Li
X and Safe S: The oncogenic microRNA-27a targets genes that
regulate specificity protein transcription factors and the G2-M
checkpoint in MDA-MB-231 breast cancer cells. Cancer Res.
67:11001–11011. 2007. View Article : Google Scholar
|
6
|
Fabbri M, Garzon R, Cimmino A, et al:
MicroRNA-29 family reverts aberrant methylation in lung cancer by
targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci USA.
104:15805–15810. 2007. View Article : Google Scholar : PubMed/NCBI
|
7
|
Stefani G and Slack FJ: Small non-coding
RNAs in animal development. Nat Rev Mol Cell Biol. 9:219–230. 2008.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Williams AE, Moschos SA, Perry MM, Barnes
PJ and Lindsay MA: Maternally imprinted microRNAs are
differentially expressed during mouse and human lung development.
Dev Dyn. 236:572–580. 2007. View Article : Google Scholar : PubMed/NCBI
|
9
|
Williams AE, Perry MM, Moschos SA and
Lindsay MA: microRNA expression in the aging mouse lung. BMC
Genomics. 8:1722007. View Article : Google Scholar : PubMed/NCBI
|
10
|
Johnson CD, Esquela-Kerscher A, Stefani G,
et al: The let-7 microRNA represses cell proliferation pathways in
human cells. Cancer Res. 67:7713–7722. 2007. View Article : Google Scholar : PubMed/NCBI
|
11
|
Tomankova T, Petrek M and Kriegova E:
Involvement of microRNAs in physiological and pathological
processes in the lung. Respir Res. 11:1592010. View Article : Google Scholar : PubMed/NCBI
|
12
|
Lu Y, Thomson JM, Wong HY, Hammond SM and
Hogan BL: Transgenic overexpression of the microRNA miR-17-92
cluster promotes proliferation and inhibits differentiation of lung
epithelial progenitor cells. Dev Biol. 310:442–453. 2007.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Ventura A, Young AG, Winslow MM, et al:
Targeted deletion reveals essential and overlapping functions of
the miR-17 through 92 family of miRNA clusters. Cell. 132:875–886.
2008. View Article : Google Scholar : PubMed/NCBI
|
14
|
Parker LH, Schmidt M, Jin SW, et al: The
endothelial-cell-derived secreted factor Egfl7 regulates vascular
tube formation. Nature. 428:754–758. 2004. View Article : Google Scholar : PubMed/NCBI
|
15
|
Fish JE, Santoro MM, Morton SU, Yu S, Yeh
RF, Wythe JD, Ivey KN, Bruneau BG, Stainier DY and Srivastava D:
miR-126 regulates angiogenic signaling and vascular integrity. Dev
Cell. 15:272–284. 2008. View Article : Google Scholar : PubMed/NCBI
|
16
|
Jevnaker AM, Khuu C, Kjøle E, Bryne M and
Osmundsen H: Expression of members of the miRNA17-92 cluster during
development and in carcinogenesis. J Cell Physiol. 226:2257–2266.
2011. View Article : Google Scholar : PubMed/NCBI
|
17
|
Carraro G, El-Hashash A, Guidolin D, et
al: miR-17 family of microRNAs controls FGF10-mediated embryonic
lung epithelial branching morphogenesis through MAPK14 and STAT3
regulation of E-Cadherin distribution. Dev Biol. 333:238–250. 2009.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Lagos-Quintana M, Rauhut R, Yalcin A,
Meyer J, Lendeckel W and Tuschl T: Identification of tissue
specific microRNAs from mouse. Curr Biol. 12:735–739. 2002.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Naora H and Deacon NJ: Relationship
between the total size of exons and introns in protein-coding genes
of higher eukaryotes. Proc Natl Acad Sci USA. 79:6196–6200. 1982.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Clement JQ, Qian L, Kaplinsky N and
Wilkinson MF: The stability and fate of a spliced intron from
vertebrate cells. RNA. 5:206–220. 1999. View Article : Google Scholar : PubMed/NCBI
|
21
|
Soncin F, Mattot V, Lionneton F, Spruyt N,
Lepretre F, Begue A and Stehelin D: VE-statin, an endothelial
repressor of smooth muscle cell migration. EMBO J. 22:5700–5711.
2003. View Article : Google Scholar : PubMed/NCBI
|
22
|
Fitch MJ, Campagnolo L, Kuhnert F and
Stuhlmann H: EGFL7, a novel epidermal growth factordomain gene
expressed in endothelial cells. Dev Dyn. 230:316–324. 2004.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Campagnolo L, Leahy A, Chitnis S,
Koschnick S, Fitchx MJ, Fallon JT, Loskutoff D, Taubman MB and
Stuhlmann H: EGFL7 is a chemoattractant for endothelial cells and
is upregulated in angiogenesis and arterial injury. Am J Pathol.
167:275–284. 2005. View Article : Google Scholar : PubMed/NCBI
|
24
|
Wang S, Aurora AB, Johnson BA, Qi X,
McAnally J, Hill JA, Richardson JA, Bassel-Duby R and Olson EN: The
endothelial-specific microRNA miR-126 governs vascular integrity
and angiogenesis. Dev Cell. 15:261–271. 2008. View Article : Google Scholar : PubMed/NCBI
|
25
|
Liu B, Peng XC, Zheng XL, Wang J and Qin
YW: MiR-126 restoration downregulate VEGF and inhibit the growth of
lung cancer cell lines in vitro and in vivo. Lung
Cancer. 66:169–175. 2009. View Article : Google Scholar : PubMed/NCBI
|
26
|
Zhu N, Zhang D, Xie H, et al:
Endothelial-specific intron-derived miR-126 is downregulated in
human breast cancer and targets both VEGFA and PIK3R2. Mol Cell
Biochem. 351:157–164. 2011. View Article : Google Scholar : PubMed/NCBI
|
27
|
Crawford M, Brawner E, Batte K, Yu L,
Hunter MG, Otterson GA, Nuovo G, Marsh CB and Nana-Sinkam SP:
MicroRNA-126 inhibits invasion in non-small cell lung carcinoma
cell lines. Biochem Biophys Res Commun. 373:607–612. 2008.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Yang Y, Li X, Yang Q, Wang X, Zhou Y,
Jiang T, Ma Q and Wang YJ: The role of microRNA in human lung
squamous cell carcinoma. Cancer Genet Cytogenet. 200:127–133. 2010.
View Article : Google Scholar : PubMed/NCBI
|
29
|
Meister J and Schmidt MH: miR-126 and
miR-126*: new players in cancer. Sci World J. 10:2090–2100.
2010.
|
30
|
Musiyenko A, Bitko V and Barik S: Ectopic
expression of miR-126*, an intronic product of the vascular
endothelial EGF-like 7 gene, regulates prostein translation and
invasiveness of prostate cancer LNCaP cells. J Mol Med (Berlin).
86:313–322. 2008.
|
31
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Saito Y, Friedman JM, Chihara Y, Egger G,
Chuang JC and Liang G: Epigenetic therapy upregulates the tumor
suppressor microRNA-126 and its host gene EGFL7 in human cancer
cells. Biochem Biophys Res Commun. 379:726–731. 2009. View Article : Google Scholar : PubMed/NCBI
|
33
|
Ro S, Park C, Young D, Sanders KM and Yan
W: Tissue-dependent paired expression of miRNAs. Nucleic Acids Res.
35:5944–5953. 2007. View Article : Google Scholar : PubMed/NCBI
|
34
|
Okamura K, Phillips MD, Tyler DM, Duan H,
Chou YT and Lai EC: The regulatory activity of microRNA* species
has substantial influence on microRNA and 3′ UTR evolution. Nat
Struct Mol Biol. 15:354–363. 2008.
|
35
|
Li X, Shen Y, Ichikawa H, Antes T and
Goldberg GS: Regulation of miRNA expression by Src and contact
normalization: effects on nonanchored cell growth and migration.
Oncogene. 28:4272–4283. 2009. View Article : Google Scholar : PubMed/NCBI
|